Impact of socioeconomic status on survival for patients with anal cancer.

Abstract:

BACKGROUND:Although outcomes for patients with squamous cell carcinoma of the anus (SCCA) have improved, the gains in benefit may not be shared uniformly among patients of disparate socioeconomic status. In the current study, the authors investigated whether area-based median household income (MHI) is predictive of survival among patients with SCCA. METHODS:Patients diagnosed with SCCA from 2004 through 2013 in the Surveillance, Epidemiology, and End Results registry were included. Socioeconomic status was defined by census-tract MHI level and divided into quintiles. Multivariable Cox proportional hazards models and logistic regression were used to study predictors of survival and radiotherapy receipt. RESULTS:A total of 9550 cases of SCCA were included. The median age of the patients was 58 years, 63% were female, 85% were white, and 38% were married. In multivariable analyses, patients living in areas with lower MHI were found to have worse overall survival and cancer-specific survival (CSS) compared with those in the highest income areas. Mortality hazard ratios for lowest to highest income were 1.32 (95% confidence interval [95% CI], 1.18-1.49), 1.31 (95% CI, 1.16-1.48), 1.19 (95% CI, 1.06-1.34), and 1.16 (95% CI, 1.03-1.30). The hazard ratios for CSS similarly ranged from 1.34 to 1.22 for lowest to highest income. Older age, black race, male sex, unmarried marital status, an earlier year of diagnosis, higher tumor grade, and later American Joint Committee on Cancer stage of disease also were associated with worse CSS. Income was not found to be associated with the odds of initiating radiotherapy in multivariable analysis (odds ratio of 0.87 for lowest to highest income level; 95% CI, 0.63-1.20). CONCLUSIONS:MHI appears to independently predict CSS and overall survival in patients with SCCA. Black race was found to remain a predictor of SCCA survival despite controlling for income. Further study is needed to understand the mechanisms by which socioeconomic inequalities affect cancer care and outcomes. Cancer 2018;124:1791-7. © 2018 American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Lin D,Gold HT,Schreiber D,Leichman LP,Sherman SE,Becker DJ

doi

10.1002/cncr.31186

subject

Has Abstract

pub_date

2018-04-15 00:00:00

pages

1791-1797

issue

8

eissn

0008-543X

issn

1097-0142

journal_volume

124

pub_type

杂志文章

相关文献

CANCER文献大全
  • High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.

    abstract:BACKGROUND:The role of myeloablative chemotherapy in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors (MB/ST-PNET) is controversial, in particular in patients who develop recurrent disease after craniospinal radiotherapy. METHODS:In this retrospective analysis, the authors in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24341

    authors: Butturini AM,Jacob M,Aguajo J,Vander-Walde NA,Villablanca J,Jubran R,Erdreich-Epstein A,Marachelian A,Dhall G,Finlay JL

    更新日期:2009-07-01 00:00:00

  • New strategies are needed in diffuse malignant mesothelioma.

    abstract:BACKGROUND:Medical records of 50 patients with malignant mesothelioma were reviewed to determine the clinical features and factors influencing survival. METHODS:Charts of all patients whose conditions were diagnosed as malignant mesothelioma were abstracted and analyzed by statistical software. RESULTS:The male-to-fe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921215)70:12<2969::aid-cncr282

    authors: Sridhar KS,Doria R,Raub WA Jr,Thurer RJ,Saldana M

    更新日期:1992-12-15 00:00:00

  • The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.

    abstract::Carcinoembryonic antigen (CEA) values in 529 patients treated in two consecutive adjuvant chemotherapy protocols were analyzed to determine if CEA values correlated with disease-free status or prognostic utility. CEA values were evaluated preoperatively, before chemotherapy, at the conclusion of chemotherapy, and duri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890301)63:5<828::aid-cncr28206

    authors: Theriault RL,Hortobagyi GN,Fritsche HA,Frye D,Martinez R,Buzdar AU

    更新日期:1989-03-01 00:00:00

  • Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.

    abstract:BACKGROUND:Serum alpha-L-fucosidase activity is considered a marker of hepatocellular carcinoma. To the authors' knowledge, its clinical usefulness in the early detection of hepatocellular carcinoma in the follow-up of cirrhotic patients has not been reported previously. METHODS:The authors prospectively studied serum...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Giardina MG,Matarazzo M,Morante R,Lucariello A,Varriale A,Guardasole V,De Marco G

    更新日期:1998-12-15 00:00:00

  • Prognostic factors in cervical carcinoma: implications in staging and management.

    abstract::Individualization of treatment using judicious combinations of external and intracavitary irradiation remains the cornerstone of the radiation management of carcinoma of the cervix. The inherent propensity of this cancer to either confine itself to the pelvis or else spread in a systematic and predictable manner throu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810715)48:1+<560::aid-cncr2820

    authors: Rotman M,John M,Boyce J

    更新日期:1981-07-15 00:00:00

  • Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer.

    abstract::A retrospective analysis of a series of 162 patients treated for isolated chest wall recurrence of breast cancer after mastectomy was undertaken. Cumulative survival, distant relapse-free survival, and freedom from local progression after 5 years from the diagnosis of recurrence were 34%, 28%, and 45% respectively. Fi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870715)60:2<240::aid-cncr28206

    authors: Magno L,Bignardi M,Micheletti E,Bardelli D,Plebani F

    更新日期:1987-07-15 00:00:00

  • A nonrandom association between gastrointestinal stromal tumors and myeloid leukemia.

    abstract:BACKGROUND:Gastrointestinal stromal tumors (GISTs) are KIT-positive mesenchymal tumors of the gastrointestinal tract that are driven by activated KIT-signalling or platelet-derived growth factor receptor-alpha (PDFGRA) signaling. These tumors most commonly occur in the stomach and small intestine and encompass a clinic...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23216

    authors: Miettinen M,Kraszewska E,Sobin LH,Lasota J

    更新日期:2008-02-01 00:00:00

  • Cancer incidence in Norwegian Seventh-Day Adventists 1961 to 1986. Is the cancer-life-style association overestimated?

    abstract::Standardized incidence ratio for cancer in Norwegian Seventh-Day Adventists compared with the general population was not significantly different from unity (men 91, women 97). Persons converting late in life had a higher incidence than those converting at an earlier age. Respiratory cancers (standardized incidence rat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910801)68:3<666::aid-cncr28206

    authors: Fønnebø V,Helseth A

    更新日期:1991-08-01 00:00:00

  • Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients.

    abstract:BACKGROUND:We sought to determine the impact of radical nephrectomy case volume, hospital size, and geographic region on immediate surgical outcomes for patients undergoing radical nephrectomy in academic centers across the country. METHODS:The University HealthSystem Consortium (UHC) Clinical Data Base was queried fo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24292

    authors: Mitchell RE,Lee BT,Cookson MS,Barocas DA,Duke Herrell S,Clark PE,Smith JA,Chang SS

    更新日期:2009-06-01 00:00:00

  • Bone marrow manifestations of Hodgkin's disease.

    abstract::Bone marrow trephine biopsies were performed on 107 previously untreated patients with Hodgkin's disease (HD). Fifteen patients (14%) exhibited bone marrow involvement. These consisted of two of three patients (67%) with lymphocyte depletion, six of 27 patients (22%) with mixed cellularity, five of 64 patients (8%) wi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197610)38:4<1717::aid-cncr282038

    authors: O'Carroll DI,McKenna RW,Brunning RD

    更新日期:1976-10-01 00:00:00

  • Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.

    abstract:BACKGROUND:Reduced melanoma risk has been reported with regular use of nonsteroidal anti-inflammatory drugs (NSAIDs). However, the ability of NSAIDs to reach melanocytes in vivo and modulate key biomarkers in preneoplastic lesions such as atypical nevi has not been evaluated. METHODS:This randomized, double-blind, pla...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.27540

    authors: Curiel-Lewandrowski C,Swetter SM,Einspahr JG,Hsu CH,Nagle R,Sagerman P,Tangrea J,Parnes H,Alberts DS,Chow HH

    更新日期:2012-12-01 00:00:00

  • Non-Hodgkin's lymphoma of the larynx (stage IE).

    abstract::Four cases of non-Hodgkin's lymphoma (NHL) limited to the larynx are described. All were diffuse, high-grade, B-cell lymphomas of large lymphoid cell type (three centroblastic and one immunoblastic). Immunocytochemistry was performed on three cases; two showed monoclonal cytoplasmic immunoglobulin and one showed monoc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890901)64:5<1123::aid-cncr2820

    authors: Morgan K,MacLennan KA,Narula A,Bradley PJ,Morgan DA

    更新日期:1989-09-01 00:00:00

  • Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.

    abstract:BACKGROUND:Through this study, the authors sought to investigate the biologic and immunologic effects of preoperative trastuzumab in patients with ductal carcinoma in situ (DCIS) of the breast. METHODS:Patients with DCIS were enrolled in this open-label phase 2 trial and tested for HER2. Trastuzumab was given by intra...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25399

    authors: Kuerer HM,Buzdar AU,Mittendorf EA,Esteva FJ,Lucci A,Vence LM,Radvanyi L,Meric-Bernstam F,Hunt KK,Symmans WF

    更新日期:2011-01-01 00:00:00

  • Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.

    abstract:BACKGROUND:Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) plays an important role in the process of lymphocyte-mediated cytotoxicity against malignant cells. Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL, and circulating OPG has been implicated in the protection of cells from TRAIL-mediat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20550

    authors: Mizutani Y,Matsubara H,Yamamoto K,Nan Li Y,Mikami K,Okihara K,Kawauchi A,Bonavida B,Miki T

    更新日期:2004-10-15 00:00:00

  • High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer.

    abstract::High dose methotrexate followed by citrovorum factor reversal has been utilized in twenty-six patients with advanced cancer. Four of 10 patients with head and neck cancer had an objective response. One of 7 patients with metastatic osteosarcoma to the lungs had stabilization with twenty treatments over 23 months. One ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197904)43:4<1177::aid-cncr282043

    authors: Ambinder EP,Perloff M,Ohnuma T,Biller HF,Holland JF

    更新日期:1979-04-01 00:00:00

  • Comparative genomic hybridization analysis of genetic aberrations associated with development and progression of biliary tract carcinomas.

    abstract:BACKGROUND:Little is known about genetic aberrations associated with development and progression of biliary tract carcinomas. METHODS:To study chromosomal aberrations associated with development and progression of biliary tract carcinomas, the authors used comparative genomic hybridization to examine 50 such carcinoma...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010201)91:3<570::aid-cncr1036>

    authors: Shiraishi K,Okita K,Harada T,Kusano N,Furui T,Kondoh S,Oga A,Kawauchi S,Fukumoto Y,Sasaki K

    更新日期:2001-02-01 00:00:00

  • Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer.

    abstract::Four courses of ifosfamide with mesna given by intravenous infusions were combined with bolus doxorubicin in a phase II trial to treat patients with breast cancer. Ifosfamide can deplete intracellular glutathione levels and because doxorubicin resistance may be associated with elevated levels of intracellular glutathi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900601)65:11<2421::aid-cncr282

    authors: Millward MJ,Harris AL,Cantwell BM

    更新日期:1990-06-01 00:00:00

  • Reproducibility of cytologic atypia in repeat nipple duct lavage.

    abstract:BACKGROUND:It is believed that atypical cells identified by nipple duct lavage (NDL) indicate an increased risk for breast carcinoma similar to atypical ductal hyperplasia diagnosed by tissue biopsy, but many basic performance characteristics of NDL currently are undefined. METHODS:NDL was performed in 108 patients un...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20884

    authors: Johnson-Maddux A,Ashfaq R,Cler L,Naftalis E,Leitch AM,Hoover S,Euhus DM

    更新日期:2005-03-15 00:00:00

  • Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation.

    abstract::The European Organization for Research on Treatment of Cancer (EORTC) trial 20781, concerning osteosarcoma of the limbs is reported. After definitive treatment of the primary tumor with amputation or irradiation, adjuvant treatment was given, randomized into either 9 months of chemotherapy according to a modified Rose...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19880301)61:5<1024::aid-cncr2820

    authors: Burgers JM,van Glabbeke M,Busson A,Cohen P,Mazabraud AR,Abbatucci JS,Kalifa C,Tubiana M,Lemerle JS,Voûte PA

    更新日期:1988-03-01 00:00:00

  • Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.

    abstract:BACKGROUND:To quantify the magnitude of benefit of the addition of hormone treatment (HT) to exclusive radiotherapy for locally advanced prostate cancer, a literature-based meta-analysis was conducted. METHODS:Event-based relative risks (RR) with 95% confidence intervals (CIs) were derived through a random-effect mode...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.24392

    authors: Bria E,Cuppone F,Giannarelli D,Milella M,Ruggeri EM,Sperduti I,Pinnarò P,Terzoli E,Cognetti F,Carlini P

    更新日期:2009-08-01 00:00:00

  • Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.

    abstract::The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP to two years of intermittent L-PAM in women with operable breast cancer with histologically positive axillary lymph nodes. In fully evaluable patients with a 42-month median and 3...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19820801)50:3<423::aid-cncr28205

    authors: Glucksberg H,Rivkin SE,Rasmussen S,Tranum B,Gad-el-Mawla N,Costanzi J,Hoogstraten B,Athens J,Maloney T,McCracken J,Vaughn C

    更新日期:1982-08-01 00:00:00

  • A clinical and pathological staging system for soft tissue sarcomas.

    abstract::A system for staging the clinical status of patients with soft tissue sarcomas is presented, based on the clinical characteristics of the primary tumor (size, extension), the involvement of lymph nodes, the presence of metastases, and the grade of the tumor. This represents the TNM system with grade of tumor (G) added...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197710)40:4<1562::aid-cncr282040

    authors: Russell WO,Cohen J,Enzinger F,Hajdu SI,Heise H,Martin RG,Meissner W,Miller WT,Schmitz RL,Suit HD

    更新日期:1977-10-01 00:00:00

  • Irradiation and immunotherapy: From concept to the clinic.

    abstract::In recent years, an increased understanding of T-cell-regulatory mechanisms has led to the development of a novel class of immune-checkpoint inhibitors that have robust clinical activity against a broad array of malignancies-even those that historically were not believed to be sensitive to immune therapy. With this, t...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.29889

    authors: Salama AK,Postow MA,Salama JK

    更新日期:2016-06-01 00:00:00

  • Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma.

    abstract::Nine patients from 34 to 74 years of age (median, 67 years of age) with uterine papillary serous carcinoma (UPSC) were treated with whole-abdominal radiation therapy (WART) on an adjuvant basis after cytoreductive surgery. All patients were treated with megavoltage photons to an abdominopelvic field to a median dose o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19911001)68:7<1516::aid-cncr2820

    authors: Frank AH,Tseng PC,Haffty BG,Papadopoulos DP,Kacinski BM,Dowling SW,Carcangiu ML,Kohorn EI,Chambers JT,Chambers SK

    更新日期:1991-10-01 00:00:00

  • Primary hemangiosarcoma of the spleen with angioscintigraphic demonstration of metastases.

    abstract::A case of primary hemangiosarcoma of the spleen in a 48-year-old woman is presented. Twenty-eight months after splenectomy the patient developed a severe anemia of the microangiopathic type, thrombocytopenia, and a leukoerythroblastic peripheral blood picture. In contrast to x-ray and conventional 99mTc-methylene-diph...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840415)53:8<1682::aid-cncr2820

    authors: Hermann GG,Fogh J,Graem N,Hansen OP,Hippe E

    更新日期:1984-04-15 00:00:00

  • Chemotherapy for adenocystic carcinoma.

    abstract::Seventeen patients with adenocystic carcinoma have received 34 adequate trials of chemotherapy at Princess Margaret Hospital since 1969. There have been five objective responses to chemotherapy in 4 cases, lasting from five to 24 months, and 3 other patients have had stabilized disease for a period of five to seven mo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800801)46:3<452::aid-cncr28204

    authors: Tannock IF,Sutherland DJ

    更新日期:1980-08-01 00:00:00

  • Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.

    abstract::A bolus intravenous dose of 5-fluorouracil of 600 mg/M2 was added exactly 1 hour after methotrexate administration in an established combination program including bleomycin and cisplatin for advanced squamous cell cancer of the head and neck. Results were no better than those observed previously with the three drugs, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860215)57:4<706::aid-cncr28205

    authors: Vogl SE,Komisar A,Kaplan BH,Engstrom PF,Kasule OH,Stolbach L,Lerner H,Muggia F

    更新日期:1986-02-15 00:00:00

  • Identification of novel immunogenic human leukocyte antigen-A 2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer.

    abstract:BACKGROUND:A study was undertaken to identify new immunogenic human leukocyte antigen (HLA)-A 2402-restricted epitopes from human papillomavirus (HPV) type 16 E7 protein for immunotherapy against cervical cancer. METHODS:Synthetic overlapping peptides were screened by measuring the frequency of CD8(+) cytotoxic T lymp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26468

    authors: Jang S,Kim YT,Chung HW,Lee KR,Lim JB,Lee K

    更新日期:2012-04-15 00:00:00

  • Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial.

    abstract:BACKGROUND:The treatment of patients with hepatocellular carcinoma (HCC) presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. However, the abundant vascularity of HCC presents an attractive target for antiangiogenic therapy that potentially may be tolerated by cirrhotic...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.20821

    authors: Patt YZ,Hassan MM,Lozano RD,Nooka AK,Schnirer II,Zeldis JB,Abbruzzese JL,Brown TD

    更新日期:2005-02-15 00:00:00

  • Correlates of breast reconstruction: results from a population-based study.

    abstract:BACKGROUND:Immediate or early postmastectomy breast reconstruction is performed infrequently. To the authors' knowledge, little is known regarding surgeon or patient perspectives on reconstruction treatment decisions. The purpose of the current study was to identify patient attitudes and preferences associated with bre...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.21444

    authors: Morrow M,Mujahid M,Lantz PM,Janz NK,Fagerlin A,Schwartz K,Liu L,Deapen D,Salem B,Lakhani I,Katz SJ

    更新日期:2005-12-01 00:00:00